|
NOTE: The following Minutes are provided for informational purposes only. If you would like to obtain an official copy of these Minutes, please contact the State Board of Pharmacy at 614/466-4143 for instructions and fee. |
|
STATE BOARD OF PHARMACY; 77 SOUTH HIGH STREET, ROOM
1702; COLUMBUS, OHIO 43215-6126 Tel:
614/466-4143
Fax: 614/752-4836 Eml: exec@bop.state.oh.us |
|
|
Minutes
Of The Meeting Ohio
State Board of Pharmacy June
2, 3, 4, 2003 |
|
MONDAY, JUNE 2, 2003 |
|
10:00 a.m. |
ROLL CALL |
|
|
The State Board of Pharmacy convened in Room West-B&C, 31st Floor, Vern Riffe Center for Government and the Arts, 77 South High Street, Columbus, Ohio with the following members present: Diane C. Adelman, R.Ph. (President); Robert P. Giacalone, R.Ph. (Vice-President); Suzanne R. Eastman, R.Ph.; Elizabeth I. Gregg, R.Ph.; Lawrence J. Kost, R.Ph.; Nathan S. Lipsyc, R.Ph.; Dorothy S. Teater, Public Member; and James E. Turner, R.Ph. Also present were Timothy Benedict, Acting Executive Director; William McMillen, Licensing Administrator; Mark Keeley, Legislative Affairs Administrator; Robert Cole, Compliance Supervisor; David Rowland, Legal Affairs Administrator; and Sally Ann Steuk, Assistant Attorney General. |
10:01 a.m.
|
R-2003-179 |
Mr. Turner moved that the Board cancel the reinstatement hearing scheduled for June 2, 2003 requested by Roger Elliott as moot. Confirmation has been received that Mr. Elliott is deceased. The motion was seconded by Mrs. Gregg and approved by the Board (Aye-7/Nay-0). |
10:09 a.m.
|
|
Mrs. Gregg moved that the Board go into Executive Session for the purpose of the investigation of complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Revised Code. The motion was seconded by Mr. Lipsyc and a roll call vote was conducted by President Adelman as follows: Eastman-Yes, Giacalone-Yes, Gregg-Yes, Kost-Yes, Lipsyc-Yes, Teater-Yes, and Turner-Yes. |
10:47 a.m.
|
|
Board Member Gregory Braylock, R.Ph. arrived. |
11:39 a.m.
|
|
The Executive Session ended and the meeting was opened to the public. Mr. Rowland announced that the following settlement agreements previously approved by the Board had been signed by all parties and were now effective as of the date of the Board President’s signature: |
|
R-2003-180 |
SETTLEMENT AGREEMENT WITH THE STATE BOARD OF PHARMACY (Docket No. D-021119-031) In The Matter Of: MATTHEW CHARLES CAMPBELL, R.Ph. 276 East Duquesne Street Columbiana, Ohio 44408 (R.Ph. No. 03-1-24590) This Settlement Agreement is
entered into by and between Matthew Charles Campbell and the Ohio State Board
of Pharmacy, a state agency charged with enforcing the Pharmacy Practice Act
and Dangerous Drug Distribution Act, Chapter 4729. of the Ohio Revised Code. Matthew Charles Campbell
voluntarily enters into this Agreement being fully informed of his rights
afforded under Chapter 119. of the Ohio Revised Code, including the right to
representation by counsel, the right to a formal adjudication hearing on the
issues contained herein, and the right to appeal. Matthew Charles Campbell acknowledges that by entering into
this agreement he has waived his rights under Chapter 119. of the Revised
Code. Whereas, the Board is
empowered by Section 4729.16 of the Ohio Revised Code to suspend, revoke,
place on probation, refuse to grant or renew an identification card or
enforce a monetary penalty on the license holder for violation of any of the
enumerated grounds therein. Whereas, Matthew Charles
Campbell is licensed to practice pharmacy in the State of Ohio. Whereas, on or about
November 19, 2002, pursuant to Chapter 119. of the Ohio Revised Code, Matthew
Charles Campbell was notified of the allegations or charges against him, his right to a hearing, his rights
in such hearing, and his right to submit contentions in writing. Matthew Charles Campbell requested a
hearing; it was scheduled and continued.
The November 19, 2002, Notice of Opportunity for Hearing, as amended
on April 23, 2003, contains the following allegations or charges: |
|
|
(1) |
Records of the Board of Pharmacy indicate that Matthew Charles Campbell was originally licensed in the State of Ohio on July 6, 2001, pursuant to examination, and is currently licensed to practice pharmacy in the State of Ohio. Records further reflect that on December 28, 2001, Matthew Charles Campbell became the Responsible Pharmacist at Salem Drug, Inc. pursuant to Sections 4729.27 and 4729.55 of the Ohio Revised Code and Rule 4729-5-11 of the Ohio Administrative Code. |
|
|
(2) |
Matthew Charles Campbell as the Dispensing Pharmacist and/or Responsible Pharmacist did, from August 18, 2001, to April 6, 2002, continuously failed to perform prospective drug utilization review and patient counseling, to wit: with the patient profile history before him, Matthew Charles Campbell and/or pharmacists under his control failed to review the original prescription and/or refill information for over-utilization, incorrect drug dosage and duration of drug treatment, and misuse; and Matthew Charles Campbell and/or pharmacists under his control failed to offer patient counseling when dispensing: |
|
Rx # |
|
Date |
|
Drug |
Strength |
R.Ph. |
Qty |
|
74266 74267 74268 74321 75112 75113 75114 75115 75968 75969 75970 75971 76588 |
|
7/22/00 7/22/00 7/22/00 7/24/00 8/5/00 8/5/00 8/5/00 8/5/00 8/19/00 8/19/00 8/19/00 8/19/00 8/29/00 |
|
OxyContin prednisone methotrexate azathioprine furosemide Coumadin methotrexate OxyContin Deltasone Coumadin azathioprine OxyContin OxyContin |
40 mg 10 mg 2.5 mg 50 mg 40 mg 5 mg 2.5 mg 40 mg 5 mg 5 mg 50 mg 40 mg 80 mg |
JH JH JH JH BR BR BR BR BR BR BR BR JH |
60 90 28 30 60 15 28 60 120 30 30 60 15 |
|
76811 76812 76813 76814 76815 |
|
9/1/00 9/1/00 9/1/00 9/1/00 9/1/00 |
|
furosemide methotrexate Coumadin Radiacare Gel OxyContin |
40 mg 2.5 mg 2.5 mg 4x4 sheet 40 mg |
BR BR BR BR BR |
60 28 30 90 90 |
|
82872 82873 82874 82875 82876 82877 |
|
11/29/00 11/29/00 11/29/00 11/29/00 11/29/00 11/29/00 |
|
furosemide propranolol
hydrochloride methotrexate azathioprine OxyContin OxyContin |
40 mg 40 mg 2.5 mg 50 mg 40 mg 80 mg |
BR BR BR BR BR BR |
60 90 16 15 60 6 |
|
83699 83700 83701 84684 84685 84686 84687 84688 |
|
12/9/00 12/9/00 12/9/00 12/22/00 12/22/00 12/22/00 12/22/00 12/22/00 |
|
prednisone Radiacare Gel OxyContin propranolol
hydrochloride Deltasone furosemide OxyContin OxyContin |
10 mg 4x4 sheet 80 mg 40 mg 5 mg 40 mg 80 mg 40 mg |
BR BR BR BR BR BR BR BR |
30 10 28 90 60 60 12 60 |
|
86640 86641 86642 87114 87115 87512 87520 87521 87522 87643 |
|
1/20/01 1/20/01 1/20/01 1/27/01 1/27/01 2/1/01 2/2/01 2/2/01 2/2/01 2/3/01 |
|
propranolol
hydrochloride furosemide OxyContin azathioprine OxyContin OxyContin warfarin sodium methotrexate quinine sulfate methadone hydrochloride |
40 mg 40 mg 80 mg 50 mg 40 mg 80 mg 2.5 mg 2.5 mg 260 mg 10 mg |
BR BR BR JH JH JH JH JH JH BR |
90 30 20 15 30 5 30 28 30 100 |
|
88196 88197 88507 88508 88741 88742 88743 88744 89128 89129 |
|
2/10/01 2/10/01 2/14/01 2/14/01 2/16/01 2/16/01 2/16/01 2/16/01 2/22/01 2/22/01 |
|
propranolol
hydrochloride OxyContin OxyContin azathioprine Prozac Pulvules Radiacare Gel methadone hydrochloride OxyContin furosemide OxyContin |
40 mg 80 mg 40 mg 50 mg 20 mg 4x4 sheet 10 mg 80 mg 40 mg 80 mg |
JH JH JH JH BR BR BR BR BR BR |
90 15 30 15 30 90 100 15 30 24 |
|
89625 89626 89836 89837 90331 90332 90710 90711 90836 90837 90838 |
|
3/1/01 3/1/01 3/3/01 3/3/01 3/10/01 3/10/01 3/16/01 3/16/01 3/17/01 3/17/01 3/17/01 |
|
propranolol
hydrochloride OxyContin Deltasone methadone hydrochloride OxyContin methadone hydrochloride Deltasone OxyContin warfarin sodium methadone hydrochloride OxyContin |
40 mg 80 mg 5 mg 10 mg 80 mg 10 mg 5 mg 80 mg 2.5 mg 10 mg 40 mg |
BR BR BR BR JH JH BR BR BR BR BR |
90 24 100 100 15 100 100 16 30 100 24 |
|
91212 91213 91342 91343 91344 91702 91710 91711 |
|
3/22/01 3/22/01 3/24/01 3/24/01 3/24/01 3/29/01 3/30/01 3/30/01 |
|
azathioprine OxyContin propranolol
hydrochloride methadone hydrochloride OxyContin |